SI1458386T1 - Aroil pirol heteroeril in metanoli, uporabni za zdravljenje motnje centralnega živčnega sistema - Google Patents
Aroil pirol heteroeril in metanoli, uporabni za zdravljenje motnje centralnega živčnega sistemaInfo
- Publication number
- SI1458386T1 SI1458386T1 SI200230550T SI200230550T SI1458386T1 SI 1458386 T1 SI1458386 T1 SI 1458386T1 SI 200230550 T SI200230550 T SI 200230550T SI 200230550 T SI200230550 T SI 200230550T SI 1458386 T1 SI1458386 T1 SI 1458386T1
- Authority
- SI
- Slovenia
- Prior art keywords
- heteroeryl
- methanols
- treating
- useful
- nervous system
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34376801P | 2001-12-27 | 2001-12-27 | |
| PCT/US2002/039487 WO2003057219A1 (en) | 2001-12-27 | 2002-12-10 | Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder |
| EP02799923A EP1458386B1 (en) | 2001-12-27 | 2002-12-10 | Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1458386T1 true SI1458386T1 (sl) | 2007-08-31 |
Family
ID=23347573
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200230550T SI1458386T1 (sl) | 2001-12-27 | 2002-12-10 | Aroil pirol heteroeril in metanoli, uporabni za zdravljenje motnje centralnega živčnega sistema |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US6897319B2 (sl) |
| EP (1) | EP1458386B1 (sl) |
| JP (1) | JP2005514412A (sl) |
| AR (1) | AR038664A1 (sl) |
| AT (1) | ATE359783T1 (sl) |
| AU (2) | AU2002364545A1 (sl) |
| CY (1) | CY1106658T1 (sl) |
| DE (1) | DE60219687T2 (sl) |
| DK (1) | DK1458386T3 (sl) |
| ES (1) | ES2286328T3 (sl) |
| PT (1) | PT1458386E (sl) |
| SI (1) | SI1458386T1 (sl) |
| TW (1) | TWI282277B (sl) |
| WO (2) | WO2003057219A1 (sl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602004025586D1 (de) * | 2003-08-25 | 2010-04-01 | Newron Pharm Spa | Alpha-aminoamid derivate zur verwendung als anti-inflammatorische wirkstoffe |
| EP1533298A1 (en) * | 2003-11-21 | 2005-05-25 | Newron Pharmaceuticals S.p.A. | 3-aminopyrrolidone derivatives |
| EP1533295A1 (en) * | 2003-11-24 | 2005-05-25 | Newron Pharmaceuticals S.p.A. | Cyclopentyl Derivatives |
| CN100371325C (zh) * | 2004-07-23 | 2008-02-27 | 中国科学院上海药物研究所 | 一类茚并吲哚酮类化合物、其制备方法和用途 |
| ES2347581T3 (es) * | 2004-09-10 | 2010-11-02 | Newron Pharmaceuticals S.P.A. | Uso de (r)-(halobenciloxi)bencilamino-propanamidas como moduladores selectivos del canal de sodio y/o calcio. |
| US7598380B2 (en) * | 2005-08-03 | 2009-10-06 | Bristol-Myers Squibb Company | Method of preparation of azaindole derivatives |
| AU2006329040C1 (en) | 2005-12-22 | 2011-12-08 | Newron Pharmaceuticals S.P.A. | 2 -Phenylethylamino derivatives as calcium and/or sodium channel modulators |
| CN101687773B (zh) | 2007-06-15 | 2014-07-30 | 纽朗制药有限公司 | 取代的2-[2-(苯基)乙氨基]烷酰胺衍生物及其作为钠和/或钙通道调节剂的应用 |
| GB0804755D0 (en) * | 2008-03-14 | 2008-04-16 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
| GB0813873D0 (en) * | 2008-07-30 | 2008-09-03 | Univ Dundee | Compounds |
| RU2559888C2 (ru) * | 2009-07-10 | 2015-08-20 | Зе Дженерал Хоспитал Корпорэйшн | Аналоги этомидата, которые не ингибируют синтез адренокортикостероидов |
| ME02524B (me) | 2011-06-27 | 2017-02-20 | Newron Pharm Spa | Fluorisani derivati arilalkilaminokarboksamida |
| LT2802325T (lt) | 2012-01-13 | 2017-03-10 | The General Hospital Corporation | Anesteziniai junginiai ir su jais susiję panaudojimo būdai |
| WO2022159980A1 (en) * | 2021-01-25 | 2022-07-28 | Athos Therapeutics, Inc. | Pharmaceutical compounds and methods of making and using the same |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0751767A4 (en) | 1994-02-03 | 1997-12-10 | Cambridge Neuroscience Inc | GUANIDINE FOR THERAPEUTIC USE |
| GB9509156D0 (en) | 1995-05-05 | 1995-06-28 | Sandoz Ltd | Organic compounds |
| CA2264231A1 (en) | 1996-08-29 | 1998-03-05 | Takeda Chemical Industries, Ltd. | Cyclic ether compounds as sodium channel modulators |
| MA26473A1 (fr) | 1997-03-01 | 2004-12-20 | Glaxo Group Ltd | Composes pharmacologiquement actifs. |
| US6110937A (en) | 1997-04-03 | 2000-08-29 | Syntex Usa, Inc. | Phenoxymethyl piperidine derivatives for the treatment of neuropathic pain |
| GB9726987D0 (en) | 1997-12-22 | 1998-02-18 | Glaxo Group Ltd | Compounds |
| US6256307B1 (en) * | 1998-03-27 | 2001-07-03 | Hewlett-Packard Co. | Local area network receive filter |
| WO2000002865A1 (en) | 1998-07-08 | 2000-01-20 | Monash University | Pharmaceutical agents |
| DE19834714A1 (de) | 1998-07-31 | 2000-02-03 | Boehringer Ingelheim Pharma | Neue 2,3,3a,4,9,9a-Hexahydro-8-hydroxy-1H-ben[f]indole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| US6169118B1 (en) * | 1998-11-12 | 2001-01-02 | Block Drug Company, Inc. | Flavor blend for masking unpleasant taste of zinc compounds |
| US6281211B1 (en) | 1999-02-04 | 2001-08-28 | Euro-Celtique S.A. | Substituted semicarbazides and the use thereof |
| WO2000048584A2 (en) * | 1999-02-18 | 2000-08-24 | Ortho-Mcneil Pharmaceutical, Inc. | Aroyl aminoacyl pyrroles for use in the treatment of neuropathic pain |
| CA2300698C (en) | 1999-02-19 | 2003-10-07 | J. Garfield Purdon | Broad spectrum decontamination formulation and method of use |
| DE19915602A1 (de) | 1999-04-07 | 2000-10-19 | Gruenenthal Gmbh | 3-Amino-4-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung |
| GB9907965D0 (en) | 1999-04-09 | 1999-06-02 | Glaxo Group Ltd | Medical use |
| WO2001023571A1 (en) | 1999-09-30 | 2001-04-05 | The Regents Of The University Of Michigan | Methods and compositions relating to sodium channel beta1a subunits |
-
2002
- 2002-12-10 US US10/315,585 patent/US6897319B2/en not_active Expired - Lifetime
- 2002-12-10 EP EP02799923A patent/EP1458386B1/en not_active Expired - Lifetime
- 2002-12-10 JP JP2003557577A patent/JP2005514412A/ja active Pending
- 2002-12-10 WO PCT/US2002/039487 patent/WO2003057219A1/en active IP Right Grant
- 2002-12-10 SI SI200230550T patent/SI1458386T1/sl unknown
- 2002-12-10 PT PT02799923T patent/PT1458386E/pt unknown
- 2002-12-10 AT AT02799923T patent/ATE359783T1/de active
- 2002-12-10 ES ES02799923T patent/ES2286328T3/es not_active Expired - Lifetime
- 2002-12-10 DE DE60219687T patent/DE60219687T2/de not_active Expired - Lifetime
- 2002-12-10 DK DK02799923T patent/DK1458386T3/da active
- 2002-12-10 AU AU2002364545A patent/AU2002364545A1/en not_active Abandoned
- 2002-12-23 AU AU2002359856A patent/AU2002359856A1/en not_active Abandoned
- 2002-12-23 WO PCT/US2002/041417 patent/WO2003057147A2/en not_active Application Discontinuation
- 2002-12-23 US US10/328,317 patent/US20040058980A1/en not_active Abandoned
- 2002-12-26 TW TW091137398A patent/TWI282277B/zh not_active IP Right Cessation
- 2002-12-26 AR ARP020105110A patent/AR038664A1/es active IP Right Grant
-
2005
- 2005-02-25 US US11/065,914 patent/US20050148636A1/en not_active Abandoned
-
2007
- 2007-06-14 CY CY20071100793T patent/CY1106658T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW200400030A (en) | 2004-01-01 |
| EP1458386A1 (en) | 2004-09-22 |
| AU2002364545A1 (en) | 2003-07-24 |
| TWI282277B (en) | 2007-06-11 |
| AU2002359856A1 (en) | 2003-07-24 |
| AU2002359856A8 (en) | 2003-07-24 |
| WO2003057147A2 (en) | 2003-07-17 |
| EP1458386B1 (en) | 2007-04-18 |
| AR038664A1 (es) | 2005-01-26 |
| ATE359783T1 (de) | 2007-05-15 |
| US20030181481A1 (en) | 2003-09-25 |
| CY1106658T1 (el) | 2012-01-25 |
| WO2003057147A3 (en) | 2003-10-23 |
| WO2003057219A1 (en) | 2003-07-17 |
| ES2286328T3 (es) | 2007-12-01 |
| US20050148636A1 (en) | 2005-07-07 |
| US6897319B2 (en) | 2005-05-24 |
| DK1458386T3 (da) | 2007-08-13 |
| DE60219687T2 (de) | 2007-12-27 |
| JP2005514412A (ja) | 2005-05-19 |
| DE60219687D1 (de) | 2007-05-31 |
| US20040058980A1 (en) | 2004-03-25 |
| PT1458386E (pt) | 2007-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI1458386T1 (sl) | Aroil pirol heteroeril in metanoli, uporabni za zdravljenje motnje centralnega živčnega sistema | |
| AU2002366078A8 (en) | Vehicle security and maintenance | |
| GB2373614B (en) | Vehicle security system and method | |
| EP1434801A4 (en) | TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM | |
| PT1595670E (pt) | Métodos e aparelho para produzir e tratar novos compósitos de elastómero | |
| IL160370A0 (en) | Security tag and process for making same | |
| AU3975201A (en) | System and method for providing additional insurance | |
| HK1046773B (zh) | 鍵頭及其製造方法 | |
| AU2002211688A1 (en) | Method for treating ischemic events affecting the central nervous system | |
| GB0228813D0 (en) | High-cleanliness steel and process for producing the same | |
| HK1068835A1 (en) | Method and system for treating organic matter | |
| HRP20031096A2 (en) | 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators | |
| GB2384351B (en) | System and method for secure printing | |
| EP1242094A4 (en) | METHOD FOR TREATING LIGHT COGNITIVE DISORDERS | |
| PL368284A1 (en) | Method for producing melem-free melamine and quenching agents | |
| EP1500040A4 (en) | VEHICLE SAFETY METHODS AND APPARATUSES | |
| AU3456499A (en) | Isoflavones for treating giardiasis and malaria | |
| AU2002304931A1 (en) | Methods for treating disorders of the nervous and reproductive systems | |
| EP1372082A4 (en) | AUTHENTICATION SYSTEM AND AUTHENTICATION METHOD | |
| EP1036851A4 (en) | STEEL WIRE AND HIGH FATIGUE RESISTANCE SPRING AND METHODS OF MANUFACTURE | |
| HRP20040115A2 (en) | Profile system for forming the cross-section of flat keys and of key channels | |
| GB2377533B (en) | Anti-counterfeiting method and system | |
| PL360504A1 (en) | Reactor and method for producing melamine | |
| GB2410252B (en) | High-cleanliness steel and process for producing the same | |
| GB2381700B (en) | Telecommunication security arrangements and methods |